{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:47:23Z","timestamp":1784580443302,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03005-8","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T07:27:49Z","timestamp":1758353269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bisabolol as a natural anticancer agent: molecular insights and therapeutic potential in oncology"],"prefix":"10.1007","volume":"42","author":[{"given":"Parteek","family":"Prasher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousmee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Setzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"3005_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"3005_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"3005_CR3","doi-asserted-by":"publisher","first-page":"e2138793","DOI":"10.1001\/jamanetworkopen.2021.38793","volume":"4","author":"T Olivier","year":"2021","unstructured":"Olivier T, Haslam A, Prasad V. Anticancer drugs approved by the US food and drug administration from 2009 to 2020 according to their mechanism of action. JAMA Netw Open. 2021;4:e2138793. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38793.","journal-title":"JAMA Netw Open"},{"key":"3005_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu J-J, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11:5\u201313. https:\/\/doi.org\/10.1007\/s13659-020-00293-7.","journal-title":"Nat Prod Bioprospect"},{"key":"3005_CR5","doi-asserted-by":"publisher","first-page":"100218","DOI":"10.1016\/j.ejmcr.2024.100218","volume":"12","author":"B Goel","year":"2024","unstructured":"Goel B, Jain SK. Semisynthesis: bridging natural products and novel anticancer therapies. Eur J Med Chem Rep. 2024;12:100218. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100218.","journal-title":"Eur J Med Chem Rep"},{"key":"3005_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2174\/0929867330666230502113150","volume":"31","author":"S Tauro","year":"2024","unstructured":"Tauro S, Dhokchawle B, Mohite P, Nahar D, Nadar S, Coutinho E. Natural anticancer agents: their therapeutic potential, challenges and promising outcomes. Curr Med Chem. 2024;31:848\u201370. https:\/\/doi.org\/10.2174\/0929867330666230502113150.","journal-title":"Curr Med Chem"},{"key":"3005_CR7","doi-asserted-by":"publisher","first-page":"108674","DOI":"10.1016\/j.plaphy.2024.108674","volume":"211","author":"B Hilal","year":"2024","unstructured":"Hilal B, Khan MM, Fariduddin Q. Recent advancements in deciphering the therapeutic properties of plant secondary metabolites: phenolics, terpenes, and alkaloids. Plant Physiol Biochem. 2024;211:108674. https:\/\/doi.org\/10.1016\/j.plaphy.2024.108674.","journal-title":"Plant Physiol Biochem"},{"key":"3005_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms19010263","volume":"19","author":"A Seca","year":"2018","unstructured":"Seca A, Pinto D. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci. 2018;19:263. https:\/\/doi.org\/10.3390\/ijms19010263.","journal-title":"Int J Mol Sci"},{"key":"3005_CR9","doi-asserted-by":"publisher","first-page":"105165","DOI":"10.1016\/j.phrs.2020.105165","volume":"161","author":"T Abu-Izneid","year":"2020","unstructured":"Abu-Izneid T, Rauf A, Shariati MA, Khalil AA, Imran M, Rebezov M, Uddin MS, Mahomoodally MF, Rengasamy KRR. Sesquiterpenes and their derivatives-natural anticancer compounds: an update. Pharmacol Res. 2020;161:105165. https:\/\/doi.org\/10.1016\/j.phrs.2020.105165.","journal-title":"Pharmacol Res"},{"key":"3005_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.phrs.2019.04.004","volume":"144","author":"K Banik","year":"2019","unstructured":"Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets. Pharmacol Res. 2019;144:192\u2013209.","journal-title":"Pharmacol Res"},{"key":"3005_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1080\/17460441.2023.2147920","volume":"17","author":"IA Cheikh","year":"2022","unstructured":"Cheikh IA, El-Baba C, Youssef A, Saliba NA, Ghantous A, Darwiche N. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention. Expert Opin Drug Discov. 2022;17:1377\u2013405. https:\/\/doi.org\/10.1080\/17460441.2023.2147920.","journal-title":"Expert Opin Drug Discov"},{"key":"3005_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02721-9","volume":"22","author":"P Dhyani","year":"2022","unstructured":"Dhyani P, Sati P, Sharma E, Attri DC, Bahukhandi A, Tynybekov B, Szopa A, Sharifi-Rad J, Calina D, Suleria HAR, Cho WC. Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies. Cancer Cell Int. 2022;22: 305. https:\/\/doi.org\/10.1186\/s12935-022-02721-9.","journal-title":"Cancer Cell Int"},{"key":"3005_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11746-009-1483-3","volume":"87","author":"GPP Kamatou","year":"2010","unstructured":"Kamatou GPP, Viljoen AM. A review of the application and pharmacological properties of \u03b1 -bisabolol and \u03b1 -bisabolol-rich oils. J Am Oil Chem Soc. 2010;87:1\u20137. https:\/\/doi.org\/10.1007\/s11746-009-1483-3.","journal-title":"J Am Oil Chem Soc"},{"key":"3005_CR14","doi-asserted-by":"publisher","first-page":"120728","DOI":"10.1016\/j.lfs.2022.120728","volume":"304","author":"E Ramazani","year":"2022","unstructured":"Ramazani E, Akaberi M, Emami SA, Tayarani-Najaran Z. Pharmacological and biological effects of alpha-bisabolol: an updated review of the molecular mechanisms. Life Sci. 2022;304:120728. https:\/\/doi.org\/10.1016\/j.lfs.2022.120728.","journal-title":"Life Sci"},{"key":"3005_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00210-011-0679-x","volume":"384","author":"NFM Rocha","year":"2011","unstructured":"Rocha NFM, Rios ERV, Carvalho AMR, Cerqueira GS, Lopes AdeA, Leal LKAM, Dias ML, Sousa DPde, Sousa FCFde. Anti-nociceptive and anti-inflammatory activities of (\u2212)-\u03b1-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol. 2011;384:525\u201333. https:\/\/doi.org\/10.1007\/s00210-011-0679-x.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3005_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.110948","volume":"190","author":"S Sathya","year":"2020","unstructured":"Sathya S, Shanmuganathan B, Devi KP. Deciphering the anti-apoptotic potential of \u03b1-bisabolol loaded solid lipid nanoparticles against A\u03b2 induced neurotoxicity in Neuro-2a cells. Colloids Surf, B. 2020;190: 110948. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.110948.","journal-title":"Colloids Surf, B"},{"key":"3005_CR17","first-page":"1407","volume":"23","author":"S Wu","year":"2018","unstructured":"Wu S, Peng L, Sang H, Li QP, Cheng S. Anticancer effects of \u03b1-bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K\/AKT signalling pathway. J BUON. 2018;23:1407\u201312.","journal-title":"J BUON"},{"key":"3005_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/nu14071370","volume":"14","author":"LB Eddin","year":"2022","unstructured":"Eddin LB, Jha NK, Goyal SN, Agrawal YO, Subramanya SB, Bastaki SMA, Ojha S. Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of \u03b1-bisabolol. Nutrients. 2022;14:1370. https:\/\/doi.org\/10.3390\/nu14071370.","journal-title":"Nutrients"},{"key":"3005_CR19","doi-asserted-by":"publisher","unstructured":"B.A. Mendes FB, Bergamin LS, Dos Santos Stuepp C, Braganhol E, Terroso T, Pohlmann AR, Guterres SS, Alpha-bisabolol Promotes Glioma Cell Death by Modulating the Adenosinergic System, Anticancer Res. 37 (2017) 1819\u20131823. https:\/\/doi.org\/10.21873\/anticanres.11516.","DOI":"10.21873\/anticanres.11516"},{"key":"3005_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.abb.2008.02.004","volume":"476","author":"E Darra","year":"2008","unstructured":"Darra E, Abdel-Azeim S, Manara A, Shoji K, Mar\u00e9chal J-D, Mariotto S, Cavalieri E, Perbellini L, Pizza C, Perahia D, Crimi M, Suzuki H. Insight into the apoptosis-inducing action of \u03b1-bisabolol towards malignant tumor cells: involvement of lipid rafts and Bid. Arch Biochem Biophys. 2008;476:113\u201323. https:\/\/doi.org\/10.1016\/j.abb.2008.02.004.","journal-title":"Arch Biochem Biophys"},{"key":"3005_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046674","volume":"7","author":"M Bonifacio","year":"2012","unstructured":"Bonifacio M, Rigo A, Guardalben E, Bergamini C, Cavalieri E, Fato R, Pizzolo G, Suzuki H, Vinante F. \u03b1-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL+ Cells in Synergism with Imatinib and Nilotinib. PLoS ONE. 2012;7: e46674. https:\/\/doi.org\/10.1371\/journal.pone.0046674.","journal-title":"PLoS ONE"},{"key":"3005_CR22","doi-asserted-by":"publisher","first-page":"13172","DOI":"10.1073\/pnas.240454797","volume":"97","author":"BM Lange","year":"2000","unstructured":"Lange BM, Rujan T, Martin W, Croteau R. Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc Natl Acad Sci U S A. 2000;97:13172\u20137. https:\/\/doi.org\/10.1073\/pnas.240454797.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3005_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021730","volume":"24","author":"Y Tai","year":"2023","unstructured":"Tai Y, Wang H, Yao P, Sun J, Guo C, Jin Y, Yang L, Chen Y, Shi F, Yu L, Li S, Yuan Y. Biosynthesis of \u03b1-bisabolol by farnesyl diphosphate synthase and \u03b1-bisabolol synthase and their related transcription factors in Matricaria recutita L. Int J Mol Sci. 2023;24: 1730. https:\/\/doi.org\/10.3390\/ijms24021730.","journal-title":"Int J Mol Sci"},{"key":"3005_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/catal9050432","volume":"9","author":"S-J Kim","year":"2019","unstructured":"Kim S-J, Kim SK, Seong W, Woo S-G, Lee H, Yeom S-J, Kim H, Lee D-H, Lee S-G. Enhanced (\u2212)-\u03b1-bisabolol productivity by efficient conversion of mevalonate in Escherichia coli. Catalysts. 2019;9: 432. https:\/\/doi.org\/10.3390\/catal9050432.","journal-title":"Catalysts"},{"key":"3005_CR25","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1021\/acs.jafc.1c02759","volume":"69","author":"HS Lim","year":"2021","unstructured":"Lim HS, Kim SK, Woo S-G, Kim TH, Yeom S-J, Yong W, Ko Y-J, Kim S-J, Lee S-G, Lee D-H. (\u2212)-\u03b1-bisabolol production in engineered Escherichia coli expressing a novel (\u2212)-\u03b1-bisabolol synthase from the globe artichoke Cynara cardunculus var. Scolymus. J Agric Food Chem. 2021;69:8492\u2013503. https:\/\/doi.org\/10.1021\/acs.jafc.1c02759.","journal-title":"J Agric Food Chem"},{"key":"3005_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-016-0588-2","volume":"15","author":"GH Han","year":"2016","unstructured":"Han GH, Kim SK, Yoon PK-S, Kang Y, Kim BS, Fu Y, Sung BH, Jung HC, Lee D-H, Kim S-W, Lee S-G. Fermentative production and direct extraction of (\u2212)-\u03b1-bisabolol in metabolically engineered Escherichia coli. Microb Cell Fact. 2016;15: 185. https:\/\/doi.org\/10.1186\/s12934-016-0588-2.","journal-title":"Microb Cell Fact"},{"key":"3005_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jbiotec.2021.08.008","volume":"340","author":"TY Kim","year":"2021","unstructured":"Kim TY, Park H, Kim S-K, Kim S-J, Park Y-C. Production of (\u2212)-\u03b1-bisabolol in metabolically engineered Saccharomyces cerevisiae. J Biotechnol. 2021;340:13\u201321. https:\/\/doi.org\/10.1016\/j.jbiotec.2021.08.008.","journal-title":"J Biotechnol"},{"key":"3005_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.synbio.2023.01.004","volume":"8","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Xia L, Gao S, Li N, Yu S, Zhou J. Engineering Saccharomyces cerevisiae for enhanced (\u2013)-\u03b1-bisabolol production. Synth Syst Biotechnol. 2023;8:187\u201395. https:\/\/doi.org\/10.1016\/j.synbio.2023.01.004.","journal-title":"Synth Syst Biotechnol"},{"key":"3005_CR29","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1021\/acs.jafc.4c11904","volume":"73","author":"N Zhang","year":"2025","unstructured":"Zhang N, Huang Z-Y, Li H-P, Li C-X, Xu J-H. Reprogramming Komagataella phaffii for a robust chassis toward efficient de novo biosynthesis of (\u2212)-\u03b1-bisabolol. J Agric Food Chem. 2025;73:8381\u201390. https:\/\/doi.org\/10.1021\/acs.jafc.4c11904.","journal-title":"J Agric Food Chem"},{"key":"3005_CR30","doi-asserted-by":"publisher","unstructured":"M. Bugnon, M. Goullieux, U.F. R\u00f6hrig, M.A.S. Perez, A. Daina, O. Michielin, V. Zoete, SwissParam 2023: A Modern Web-Based Tool for Efficient Small Molecule Parametrization, J. Chem. Inf. Model. 63 (2023) 6469\u20136475. https:\/\/doi.org\/10.1021\/acs.jcim.3c01053.","DOI":"10.1021\/acs.jcim.3c01053"},{"key":"3005_CR31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: A fast force field generation tool for small organic molecules. J Comput Chem. 2011;32:2359\u201368. https:\/\/doi.org\/10.1002\/jcc.21816.","journal-title":"J Comput Chem"},{"key":"3005_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"3005_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"3005_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387. https:\/\/doi.org\/10.1016\/j.blre.2019.04.005.","journal-title":"Blood Rev"},{"key":"3005_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.V118.21.1319.1319","volume":"118","author":"M Bonifacio","year":"2011","unstructured":"Bonifacio M, Rigo A, Bonalumi A, Guardalben E, Nichele I, Sissa C, Cavalieri E, Bergamini C, Pizzolo G, Suzuki H, Vinante F. The sesquiterpene oil \u03b1-bisabolol induces apoptosis of B-chronic lymphocytic leukemia primary cells. Blood. 2011;118:1319\u20131319. https:\/\/doi.org\/10.1182\/blood.V118.21.1319.1319.","journal-title":"Blood"},{"key":"3005_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-45","volume":"9","author":"E Cavalieri","year":"2011","unstructured":"Cavalieri E, Rigo A, Bonifacio M, de Prati AC, Guardalben E, Bergamini C, Fato R, Pizzolo G, Suzuki H, Vinante F. Pro-apoptotic activity of \u03b1-bisabolol in preclinical models of primary human acute leukemia cells. J Transl Med. 2011;9: 45. https:\/\/doi.org\/10.1186\/1479-5876-9-45.","journal-title":"J Transl Med"},{"key":"3005_CR37","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1182\/blood.V114.22.4800.4800","volume":"114","author":"M Bonifacio","year":"2009","unstructured":"Bonifacio M, Cavalieri E, Rigo A, de Prati AC, Pizzolo G, Vinante F, Suzuki H. The plant-derived agent \u03b1-bisabolol induces apoptosis of leukemic blasts ex vivo. Blood. 2009;114:4800\u20134800. https:\/\/doi.org\/10.1182\/blood.V114.22.4800.4800.","journal-title":"Blood"},{"key":"3005_CR38","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1182\/blood.V116.21.4456.4456","volume":"116","author":"M Bonifacio","year":"2010","unstructured":"Bonifacio M, Rigo A, Cavalieri E, Guardalben E, Bergamini C, Pizzolo G, Suzuki H, Vinante F. Mitochondrial-mediated apoptosis by the sesquiterpene oil \u03b1-bisabolol and its synergism with Imatinib and Nilotinib in BCR-ABL+ cells. Blood. 2010;116:4456\u20134456. https:\/\/doi.org\/10.1182\/blood.V116.21.4456.4456.","journal-title":"Blood"},{"key":"3005_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbrc.2004.01.088","volume":"315","author":"E Cavalieri","year":"2004","unstructured":"Cavalieri E, Mariotto S, Fabrizi C, de Prati AC, Gottardo R, Leone S, Berra LV, Lauro GM, Ciampa AR, Suzuki H. \u03b1-bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem Biophys Res Commun. 2004;315:589\u201394. https:\/\/doi.org\/10.1016\/j.bbrc.2004.01.088.","journal-title":"Biochem Biophys Res Commun"},{"key":"3005_CR40","doi-asserted-by":"publisher","first-page":"25877","DOI":"10.18632\/oncotarget.25398","volume":"9","author":"A Rigo","year":"2018","unstructured":"Rigo A, Ferrarini I, Bonalumi A, Tecchio C, Montresor A, Laudanna C, Vinante F. Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol \u03b1-bisabolol, a dual proapoptotic and antiautophagic agent. Oncotarget. 2018;9:25877\u201390. https:\/\/doi.org\/10.18632\/oncotarget.25398.","journal-title":"Oncotarget"},{"key":"3005_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10495-016-1257-y","volume":"21","author":"A Rigo","year":"2016","unstructured":"Rigo A, Vinante F. The antineoplastic agent \u03b1-bisabolol promotes cell death by inducing pores in mitochondria and lysosomes. Apoptosis. 2016;21:917\u201327. https:\/\/doi.org\/10.1007\/s10495-016-1257-y.","journal-title":"Apoptosis"},{"key":"3005_CR42","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375. https:\/\/doi.org\/10.1038\/s41580-023-00585-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3005_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528230","author":"P Jalali","year":"2025","unstructured":"Jalali P, Shahmoradi A, Samii A, Mazloomnejad R, Hatamnejad MR, Saeed A, Namdar A, Salehi Z. The role of autophagy in cancer: from molecular mechanism to therapeutic window. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1528230.","journal-title":"Front Immunol"},{"key":"3005_CR44","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1016\/j.ejmech.2010.03.026","volume":"45","author":"AP da Silva","year":"2010","unstructured":"da Silva AP, Martini MV, de Oliveira CMA, Cunha S, de Carvalho JE, Ruiz ALTG, da Silva CC. Antitumor activity of (\u2212)-\u03b1-bisabolol-based thiosemicarbazones against human tumor cell lines. Eur J Med Chem. 2010;45:2987\u201393. https:\/\/doi.org\/10.1016\/j.ejmech.2010.03.026.","journal-title":"Eur J Med Chem"},{"key":"3005_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jso.26296","volume":"123","author":"PD Leiphrakpam","year":"2021","unstructured":"Leiphrakpam PD, Chowdhury S, Wang J, Black JD, Are C. The role and therapeutic implications of PI3K signaling pathway in cancer. J Surg Oncol. 2021;123:39\u201341. https:\/\/doi.org\/10.1002\/jso.26296.","journal-title":"J Surg Oncol"},{"key":"3005_CR46","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1007\/s00018-021-03771-4","volume":"78","author":"S Dadsena","year":"2021","unstructured":"Dadsena S, Jenner A, Garc\u00eda-S\u00e1ez AJ. Mitochondrial outer membrane permeabilization at the single molecule level. Cell Mol Life Sci. 2021;78:3777\u201390. https:\/\/doi.org\/10.1007\/s00018-021-03771-4.","journal-title":"Cell Mol Life Sci"},{"key":"3005_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183716","volume":"1863","author":"S Dadsena","year":"2021","unstructured":"Dadsena S, King LE, Garc\u00eda-S\u00e1ez AJ. Apoptosis regulation at the mitochondria membrane level. Biochimica et Biophysica Acta (BBA). 2021;1863: 183716. https:\/\/doi.org\/10.1016\/j.bbamem.2021.183716.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3005_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1023\/A:1020035124855","volume":"7","author":"MD Esposti","year":"2002","unstructured":"Esposti MD. The roles of bid. Apoptosis. 2002;7:433\u201340. https:\/\/doi.org\/10.1023\/A:1020035124855.","journal-title":"Apoptosis"},{"key":"3005_CR49","doi-asserted-by":"publisher","first-page":"17545","DOI":"10.1073\/pnas.0507900102","volume":"102","author":"H-E Kim","year":"2005","unstructured":"Kim H-E, Du F, Fang M, Wang X. Formation of apoptosome is initiated by cytochrome c -induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci U S A. 2005;102:17545\u201350. https:\/\/doi.org\/10.1073\/pnas.0507900102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3005_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1162662","author":"Y Xie","year":"2023","unstructured":"Xie Y, Li Y, Chen J, Ding H, Zhang X. Early growth response-1: key mediators of cell death and novel targets for cardiovascular disease therapy. Front Cardiovasc Med. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1162662.","journal-title":"Front Cardiovasc Med"},{"key":"3005_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6: 425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5.","journal-title":"Signal Transduct Target Ther"},{"key":"3005_CR52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/bcp.13021","volume":"82","author":"PS Mundi","year":"2016","unstructured":"Mundi PS, Sachdev J, McCourt C, Kalinsky K. Akt in cancer: new molecular insights and advances in drug development. Br J Clin Pharmacol. 2016;82:943\u201356. https:\/\/doi.org\/10.1111\/bcp.13021.","journal-title":"Br J Clin Pharmacol"},{"key":"3005_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-022-00860-9","volume":"29","author":"P-J Tsai","year":"2022","unstructured":"Tsai P-J, Lai Y-H, Manne RK, Tsai Y-S, Sarbassov D, Lin H-K. Akt: a key transducer in cancer. J Biomed Sci. 2022;29:76. https:\/\/doi.org\/10.1186\/s12929-022-00860-9.","journal-title":"J Biomed Sci"},{"key":"3005_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00437","author":"S Guzman","year":"2018","unstructured":"Guzman S, Brackstone M, Radovick S, Babwah AV, Bhattacharya MM. KISS1\/KISS1R in cancer: friend or foe? Front Endocrinol (Lausanne). 2018. https:\/\/doi.org\/10.3389\/fendo.2018.00437.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3005_CR55","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10555-020-09868-9","volume":"39","author":"T Ly","year":"2020","unstructured":"Ly T, Harihar S, Welch DR. KISS1 in metastatic cancer research and treatment: potential and paradoxes. Cancer Metastasis Rev. 2020;39:739\u201354. https:\/\/doi.org\/10.1007\/s10555-020-09868-9.","journal-title":"Cancer Metastasis Rev"},{"key":"3005_CR56","first-page":"583","volume":"36","author":"M Uno","year":"2016","unstructured":"Uno M, Kokuryo T, Yokoyama Y, Senga T, Nagino M. \u03b1-bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation. Anticancer Res. 2016;36:583\u20139.","journal-title":"Anticancer Res"},{"key":"3005_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.21873\/anticanres.11352","volume":"37","author":"Y Murata","year":"2017","unstructured":"Murata Y, Kokuryo T, Yokoyama Y, Yamaguchi J, Miwa T, Shibuya M, Yamamoto Y, Nagino M. The anticancer effects of novel \u03b1-bisabolol derivatives against pancreatic cancer. Anticancer Res. 2017;37:589\u201398. https:\/\/doi.org\/10.21873\/anticanres.11352.","journal-title":"Anticancer Res"},{"key":"3005_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01137-8","volume":"14","author":"H Hua","year":"2021","unstructured":"Hua H, Zhang H, Chen J, Wang J, Liu J, Jiang Y. Targeting Akt in cancer for precision therapy. J Hematol Oncol. 2021;14: 128. https:\/\/doi.org\/10.1186\/s13045-021-01137-8.","journal-title":"J Hematol Oncol"},{"key":"3005_CR59","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.21873\/anticanres.16245","volume":"43","author":"MT Kano","year":"2023","unstructured":"Kano MT, Kokuryo T, Baba T, Yamazaki K, Yamaguchi J, Sunagawa M, Ogura A, Watanabe N, Onoe S, Miyata K, Mizuno T, Uehara K, Igami T, Yokoyama Y, Ebata T, Nagino M. Cyclodextrin conjugated \u03b1-bisabolol suppresses FAK phosphorylation and induces apoptosis in pancreatic cancer. Anticancer Res. 2023;43:1009\u201316. https:\/\/doi.org\/10.21873\/anticanres.16245.","journal-title":"Anticancer Res"},{"key":"3005_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031726","volume":"23","author":"H-H Chuang","year":"2022","unstructured":"Chuang H-H, Zhen Y-Y, Tsai Y-C, Chuang C-H, Hsiao M, Huang M-S, Yang C-J. FAK in cancer: from mechanisms to therapeutic strategies. Int J Mol Sci. 2022;23: 1726. https:\/\/doi.org\/10.3390\/ijms23031726.","journal-title":"Int J Mol Sci"},{"key":"3005_CR61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-020-0447-4","volume":"52","author":"JM Murphy","year":"2020","unstructured":"Murphy JM, Rodriguez YAR, Jeong K, Ahn E-YE, Lim S-TS. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment. Exp Mol Med. 2020;52:877\u201386. https:\/\/doi.org\/10.1038\/s12276-020-0447-4.","journal-title":"Exp Mol Med"},{"key":"3005_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1274209","author":"H-H Hu","year":"2024","unstructured":"Hu H-H, Wang S-Q, Shang H-L, Lv H-F, Chen B-B, Gao S-G, Chen X-B. Roles and inhibitors of FAK in cancer: current advances and future directions. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1274209.","journal-title":"Front Pharmacol"},{"key":"3005_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93: 102693. https:\/\/doi.org\/10.1016\/j.canep.2024.102693.","journal-title":"Cancer Epidemiol"},{"key":"3005_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2023.103005","volume":"56","author":"C Kiruthiga","year":"2024","unstructured":"Kiruthiga C, Balan DJ, Jafni S, Anandan DP, Devi KP. Phytol and (\u2212)-\u03b1-bisabolol synergistically trigger intrinsic apoptosis through redox and Ca2+ imbalance in non-small cell lung cancer. Biocatal Agric Biotechnol. 2024;56: 103005. https:\/\/doi.org\/10.1016\/j.bcab.2023.103005.","journal-title":"Biocatal Agric Biotechnol"},{"key":"3005_CR65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2174\/0118715206289038240214102951","volume":"24","author":"C Kiruthiga","year":"2024","unstructured":"Kiruthiga C, Niharika K, Devi KP. Phytol and \u03b1-bisabolol synergy induces autophagy and apoptosis in A549 cells and additional molecular insights through comprehensive proteome analysis via nano LC-MS\/MS. Anticancer Agents Med Chem. 2024;24:773\u201388. https:\/\/doi.org\/10.2174\/0118715206289038240214102951.","journal-title":"Anticancer Agents Med Chem"},{"key":"3005_CR66","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/IJN.S195048","volume":"14","author":"K Anwer","year":"2019","unstructured":"Anwer K, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine. 2019;14:1587\u201395. https:\/\/doi.org\/10.2147\/IJN.S195048.","journal-title":"Int J Nanomedicine"},{"key":"3005_CR67","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1007\/s00210-023-02935-2","volume":"397","author":"C Kiruthiga","year":"2024","unstructured":"Kiruthiga C, Balan DJ, Prasath NH, Manikandakrishnan M, Jafni S, Prabhu NM, Pandian SK, Devi KP. Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol\/\u03b1-bisabolol nanoparticles. Naunyn-Schmiedebergs Arch Pharmacol. 2024;397:5131\u201344. https:\/\/doi.org\/10.1007\/s00210-023-02935-2.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"3005_CR68","doi-asserted-by":"publisher","unstructured":"A. Perry, P. Wesseling, Histologic classification of gliomas, in: 2016: pp. 71\u201395. https:\/\/doi.org\/10.1016\/B978-0-12-802997-8.00005-0.","DOI":"10.1016\/B978-0-12-802997-8.00005-0"},{"key":"3005_CR69","doi-asserted-by":"publisher","unstructured":"A.F. TAMIMI, M. JUWEID, Epidemiology and Outcome of Glioblastoma, in: Glioblastoma, Codon Publications, 2017: pp. 143\u2013153. https:\/\/doi.org\/10.15586\/codon.glioblastoma.2017.ch8.","DOI":"10.15586\/codon.glioblastoma.2017.ch8"},{"key":"3005_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions, CA. Cancer J Clin. 2020;70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"Cancer J Clin"},{"key":"3005_CR71","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.phytochem.2008.11.013","volume":"70","author":"M Piochon","year":"2009","unstructured":"Piochon M, Legault J, Gauthier C, Pichette A. Synthesis and cytotoxicity evaluation of natural \u03b1-bisabolol \u03b2-d-fucopyranoside and analogues. Phytochemistry. 2009;70:228\u201336. https:\/\/doi.org\/10.1016\/j.phytochem.2008.11.013.","journal-title":"Phytochemistry"},{"key":"3005_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21448\/ijsm.1448325","volume":"12","author":"N Vural","year":"2025","unstructured":"Vural N, Kaymak S. In-silico investigation of alpha-bisabolol and derivatives as inhibitors of bcl-2 family proteins for targeting glioblastoma. Int J Second Metab. 2025;12:1\u201315. https:\/\/doi.org\/10.21448\/ijsm.1448325.","journal-title":"Int J Second Metab"},{"key":"3005_CR73","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/j.1349-7006.2011.02082.x","volume":"102","author":"T Seki","year":"2011","unstructured":"Seki T, Kokuryo T, Yokoyama Y, Suzuki H, Itatsu K, Nakagawa A, Mizutani T, Miyake T, Uno M, Yamauchi K, Nagino M. Antitumor effects of \u03b1-bisabolol against pancreatic cancer. Cancer Sci. 2011;102:2199\u2013205. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02082.x.","journal-title":"Cancer Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:29:03Z","timestamp":1762424943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":73,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03005-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"485"}}